Monday, November 11, 2019
- 9:00AM-11:00AM
-
Abstract Number: 1204
Improvements in Health-Related Quality of Life in Psoriatic Arthritis Patients Treated with Intravenous Golimumab, an Anti-TNFα Monoclonal Antibody: 1-Year Results of a Phase III Trial
Measures Of Healthcare Quality Poster II: Improving Care- 9:00AM-11:00AM
-
Abstract Number: 1136
Improving Access in an Academic Rheumatology Department by Reducing the No Show Rate
Health Services Research Poster II – ACR/ARP- 9:00AM-11:00AM
-
Abstract Number: 1755
Improving Adolescent Health Care Transition: Piloting the Transition Readiness Assessment Questionnaire
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1211
Improving Exercise Counselling of Patients with Inflammatory Arthritis: A Quality Improvement Project
Measures Of Healthcare Quality Poster II: Improving Care- 9:00AM-11:00AM
-
Abstract Number: 1749
Improving Eye Screening Among Pediatric Rheumatology Patients Receiving Hydroxychloroquine: Experience of a Quaternary Care Center
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1113
Improving Healthcare Quality and Reducing Cost via Online Interaction for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool
Health Services Research Poster II – ACR/ARP- 9:00AM-11:00AM
-
Abstract Number: 1199
Improving Rates of Cervical Cancer Screening and HPV Vaccination in Patients with Lupus
Measures Of Healthcare Quality Poster II: Improving Care- 9:00AM-11:00AM
-
Abstract Number: 1318
In an International, Multicentre, Double-blind, Randomised Study in Knee Osteoarthritis Patients, Diacerein Was Found as Effective as Celecoxib in Reducing Pain and Disease Symptoms
Osteoarthritis – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 1514
Inadequate Response Within a Year of Biologic and Oral Synthetic DMARD Treatment Initiation Among Psoriatic Arthritis Patients in the USA Real-World Setting
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1573
Incidence and Predictors of Atherosclerotic Vascular Events in a Multicentre Inception SLE Cohort
SLE – Clinical Poster II: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1076
Incidence of Non-serious Infections Among Live Born Infants Born to Mothers Who Used Biologic Medications During Pregnancy for the Treatment of Autoimmune Diseases
Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease- 9:00AM-11:00AM
-
Abstract Number: 1748
Incidence of Retinopathy in Individuals Who Initiated Hydroxychloroquine Therapy During Childhood
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1646
Incidence Rate and Prevalence of Valvular Heart Disease in Systemic Sclerosis: A Retrospective Cohort Study from a Single Institution
Systemic Sclerosis & Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1234
Inconsistency in Uric Acid Reference Ranges Among 20 Top United States Hospitals: What Is “Normal”?